Ticker Scorecard - RCKT Basics Company: Rocket Pharmaceuticals, Inc. IPO Date: February 18, 2015 Sector: Healthcare Industry: Biotech Market Cap: $1.11B Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 2.98% Avg Daily Range (30 D): $0.29 | 2.68% Avg Daily Range (90 D): $0.35 | 2.66% Institutional Daily Volume Avg Daily Volume: .49M Avg Daily Volume (30 D): 1.25M Avg Daily Volume (90 D): 1.03M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 2,508 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.66M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.38M Avg Closing Trade (30 D): $1.73M Avg Closing Trade (90 D): $2.02M Avg Closing Volume: 109.09K     News Oct 22, 2024 @ 5:00 PM Gene Therapy Clinical Trial Pipeline Gains Momentu... Source: Delveinsight Sep 9, 2024 @ 7:47 PM Rocket Stock Down More Than 30% in Past Six Months... Source: Zacks Jul 30, 2024 @ 6:00 AM Global Regenerative Medicine Market Size To Worth ... Source: Spherical Insights & Consulting Jul 1, 2024 @ 2:31 PM FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R... Source: Zacks Equity Research Jun 6, 2024 @ 3:31 PM Why Is Denali Therapeutics (DNLI) Up 15.6% Since L... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.71 $-.74 $-.66 Diluted EPS $-.71 $-.74 $-.66 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -66.72M $ -69.65M $ -62.05M Operating Income / Loss $ -69.42M $ -73.71M $ -67.38M Cost of Revenue $ $ $ Net Cash Flow $ 26.99M $ 3.33M $ -20.64M PE Ratio     Splits Jan 05, 2018:   4:1